Workflow
Earnings Estimate Revisions
icon
Search documents
Southwest (LUV) Surges 8.1%: Is This an Indication of Further Gains?
ZACKS· 2025-07-11 16:01
Group 1: Southwest Airlines Performance - Southwest Airlines (LUV) shares increased by 8.1% to close at $37.35, with trading volume significantly higher than usual [1] - The stock's performance is in contrast to a 3.1% gain over the past four weeks [1] Group 2: Industry Context - The positive movement in Southwest's stock is attributed to optimism in the airline industry following Delta Air Lines' better-than-expected second-quarter 2025 earnings results [2] - Delta's earnings and revenue exceeded expectations, and the restoration of full-year guidance has pleased investors [2] Group 3: Earnings Estimates and Trends - Southwest's consensus EPS estimate for the upcoming quarter has been revised down by 20.3% over the last 30 days [4] - A negative trend in earnings estimate revisions typically does not lead to price appreciation, indicating potential caution for future stock performance [4] Group 4: Comparison with JetBlue Airways - JetBlue Airways (JBLU) also saw a stock increase of 7.8% to close at $4.56, but has returned -13% over the past month [5] - JetBlue's consensus EPS estimate has changed by -85% over the past month to -$0.31, reflecting a significant decline from the previous year [6]
Here's Why Ontrak (OTRK) Could be Great Choice for a Bottom Fisher
ZACKS· 2025-07-11 14:56
A downtrend has been apparent in Ontrak, Inc. (OTRK) lately. While the stock has lost 12.4% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the ...
Greenbrier Companies (GBX) Just Overtook the 200-Day Moving Average
ZACKS· 2025-07-11 14:50
Group 1 - Greenbrier Companies (GBX) has recently reached a key level of support and has overtaken the 200-day moving average, indicating a long-term bullish trend [1] - GBX shares have increased by 20% over the past four weeks, and the company holds a Zacks Rank 2 (Buy), suggesting potential for continued growth [2] - Positive earnings estimate revisions for GBX further strengthen the bullish outlook, with no estimates decreasing in the past two months and one estimate increasing [3] Group 2 - The 200-day simple moving average is a useful tool for determining long-term market trends and serves as a support or resistance level [2] - The combination of positive earnings estimate revisions and technical indicators positions GBX as a stock to watch for potential gains [3]
Unlocking Q2 Potential of Bank of America (BAC): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - Analysts project that Bank of America (BAC) will report quarterly earnings of $0.86 per share, a 3.6% increase year over year, with revenues expected to reach $26.61 billion, up 4.9% from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 0.8%, indicating a collective reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Forecast - The 'Efficiency Ratio (FTE basis)' is expected to reach 64.5%, compared to 63.9% in the same quarter last year [5]. - The 'Book value per share of common stock' is projected at $36.85, up from $34.39 a year ago [5]. - 'Total earning assets - Average balance' is forecasted to be $2975.40 billion, compared to $2887.94 billion in the same quarter last year [6]. - 'Total nonperforming loans, leases and foreclosed properties' are expected to be $6.66 billion, up from $5.69 billion a year ago [6]. - The estimated 'Total Non-Performing Loans' is $6.62 billion, compared to $5.47 billion in the same quarter last year [7]. - The 'Tier 1 Capital Ratio' is projected at 13.0%, down from 13.5% a year ago [7]. - The 'Net Interest Income - Fully taxable-equivalent basis' is expected to reach $14.88 billion, compared to $13.86 billion last year [8]. - 'Total Noninterest Income' is projected at $11.80 billion, slightly up from $11.68 billion in the same quarter last year [8]. - 'Investment and brokerage services' are expected to reach $4.73 billion, compared to $4.32 billion a year ago [9]. - The consensus estimate for 'Investment banking fees' stands at $1.34 billion, down from $1.56 billion in the same quarter last year [9]. - 'Total fees and commissions' are expected to be $9.29 billion, compared to $8.97 billion last year [9]. Stock Performance - Shares of Bank of America have increased by 5.3% over the past month, outperforming the Zacks S&P 500 composite, which rose by 4.1% [10].
Unveiling Johnson & Johnson (JNJ) Q2 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-11 14:16
Core Viewpoint - Johnson & Johnson (JNJ) is expected to report quarterly earnings of $2.66 per share, reflecting a 5.7% decline year-over-year, while revenues are forecasted to increase by 1.5% to $22.79 billion [1] Earnings Estimates - The consensus EPS estimate has been revised 0.5% higher in the last 30 days, indicating analysts' positive reassessment of the company's performance [1][2] Revenue Estimates by Segment - **MedTech Total Sales**: Estimated at $8.25 billion, indicating a year-over-year increase of 3.7% [3] - **Innovative Medicine Worldwide Sales**: Expected to reach $14.55 billion, reflecting a 0.4% increase from the prior year [4] - **Innovative Medicine Immunology Sales**: Forecasted at $3.86 billion, showing an 18.2% decline year-over-year [4] - **Innovative Medicine Neuroscience Sales**: Anticipated to be $1.99 billion, representing an 11.6% increase [4] Specific Product Sales Estimates - **Oncology CARVYKTI Sales**: Projected at $409.72 million, indicating a significant increase of 120.3% from the previous year [5] - **Neuroscience SPRAVATO Sales**: Expected to be $371.85 million, reflecting a 37.2% increase [5] - **MedTech Cardiovascular ABIOMED Sales**: Estimated at $423.95 million, showing an 11.9% increase [6] - **MedTech Orthopaedics Hips US Sales**: Projected at $269.05 million, indicating a 1.5% increase [7] Organic Sales Growth - Analysts predict an organic sales growth of 2.7%, down from 6.6% reported in the same quarter last year [8] Stock Performance - Johnson & Johnson shares have increased by 0.7% over the past month, compared to a 4.1% increase in the Zacks S&P 500 composite [8]
Is Most-Watched Stock Emerson Electric Co. (EMR) Worth Betting on Now?
ZACKS· 2025-07-11 14:00
Emerson Electric (EMR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this maker of process controls systems, valves and analytical instruments have returned +11% over the past month versus the Zacks S&P 500 composite's +4.1% change. The Zacks Manufacturing - Electronics industry, to which Emerson Electric belongs, has gained 10% over this period. Now th ...
Seanergy Maritime Holdings (SHIP) Soars 6.8%: Is Further Upside Left in the Stock?
ZACKS· 2025-07-11 10:30
Company Overview - Seanergy Maritime Holdings Corp (SHIP) shares increased by 6.8% to close at $6.76, following notable trading volume compared to typical sessions, despite a 7.3% loss over the past four weeks [1] - The stock has gained 7% in the current month, supported by the stabilization of the Baltic Exchange's dry bulk sea freight index, with improvements in the Panamax and Supramax segments offsetting declines in Capesize rates [2] Financial Performance - The company is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year decline of 88.3%, with revenues projected at $35.13 million, down 18.5% from the same quarter last year [3] - Management remains optimistic about the Capesize market for the remainder of 2025, which could positively impact the company's future performance [3] Market Sentiment - The consensus EPS estimate for Seanergy Maritime has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [5] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook in the market [6]
Scorpio Tankers (STNG) Moves 9.2% Higher: Will This Strength Last?
ZACKS· 2025-07-11 10:06
Group 1 - Scorpio Tankers (STNG) shares increased by 9.2% to close at $45.55, with notable trading volume compared to typical sessions, and a 1.2% gain over the past four weeks [1] - The company has seen an 11% increase in shares over the past month, driven by a spike in demand for petroleum tankers due to a pause in production from major Middle Eastern exporters [1] - The upcoming quarterly earnings report is expected to show earnings of $1.01 per share, reflecting a year-over-year decline of 71.9%, with revenues projected at $215.14 million, down 42.4% from the previous year [2] Group 2 - The consensus EPS estimate for Scorpio Tankers has been revised down by 38.5% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [3] - Scorpio Tankers holds a Zacks Rank of 1 (Strong Buy), indicating strong market confidence, while Okeanis Eco Tankers Corp. (ECO), another company in the shipping industry, has a Zacks Rank of 4 (Sell) [4][5] - Okeanis Eco Tankers Corp.'s EPS estimate remains unchanged at $0.33, representing a year-over-year decline of 73.2% [5]
MP Materials (MP) Moves 50.6% Higher: Will This Strength Last?
ZACKS· 2025-07-11 09:50
Core Viewpoint - MP Materials Corp. has entered into a public-private partnership with the U.S. Department of Defense to develop a domestic rare earth magnet supply chain, leading to a significant surge in its stock price by 50.6% in the last trading session [1]. Group 1: Partnership and Manufacturing Capacity - The partnership involves the construction of the 10X Facility, which will be the second domestic magnet manufacturing facility, expected to begin commissioning in 2028 [2]. - This facility will increase MP Materials' total U.S. rare earth magnet manufacturing capacity to an estimated 10,000 metric tons, serving both defense and commercial sectors [2]. Group 2: Financial Commitments and Market Protection - Under the 10-year agreement, the DoD has established a price floor commitment of $110 per kilogram for MP Materials' products, providing a safeguard against market volatility [3]. - The DoD has committed to purchasing 100% of the magnets produced at the 10X Facility for a duration of 10 years, ensuring a stable revenue stream for the company [3]. Group 3: Earnings Expectations - MP Materials is expected to report a quarterly loss of $0.16 per share, reflecting a year-over-year change of +5.9%, with revenues projected at $43.09 million, up 37.9% from the previous year [4]. - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may be influenced by trends in earnings estimate revisions [5]. Group 4: Industry Context - MP Materials is part of the Zacks Mining - Miscellaneous industry, which includes other companies like Teck Resources Ltd, currently holding a Zacks Rank of 3 (Hold) [6]. - Teck Resources has seen a -3.9% change in its consensus EPS estimate over the past month, indicating potential challenges within the same industry [7].
Piper Sandler Companies (PIPR) Stock Jumps 4.4%: Will It Continue to Soar?
ZACKS· 2025-07-11 09:46
Company Performance - Piper Sandler Companies (PIPR) shares increased by 4.4% to close at $302.62, supported by solid trading volume, and have gained 11.5% over the past four weeks [1][2] - The stock has seen a price increase for two consecutive trading sessions, driven by growing investor optimism regarding investment banks due to a rebound in deal-making activities linked to clarity on Trump's tariff plans [2] Earnings Expectations - The company is expected to report quarterly earnings of $1.99 per share, reflecting a year-over-year decline of 21%, while revenues are projected to be $344.7 million, an increase of 1.6% from the previous year [3] - The consensus EPS estimate for Piper Sandler has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Piper Sandler belongs to the Zacks Financial - Investment Bank industry, which includes other companies like Citigroup (C), that closed 1.5% higher at $87.08, with a 9.5% return over the past month [5] - Citigroup's consensus EPS estimate has increased by 0.6% to $1.62, representing a year-over-year change of 6.6% [6]